Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1991 1
1992 1
1993 3
1995 4
1996 5
1997 6
1998 7
1999 10
2000 7
2001 10
2002 6
2003 4
2004 5
2005 5
2006 9
2007 12
2008 8
2009 6
2010 7
2011 6
2012 3
2013 3
2014 1
2015 4
2017 6
2018 1
2019 1
2020 1
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

137 results
Results by year
Filters applied: . Clear all
Page 1
In reply.
Boisdron-Celle M, Capitain O, Faroux R, Borg C, Philippe Metges J, Galais MP, Kaassis M, Bennouna J, Bouhier-Leporrier K, Francois E, Baumgaertner I, Guerin-Meyer V, Cojocarasu O, Roemer-Becuwe C, Stampfli C, Rosenfeld L, Lecompte T, Berger V, Morel A, Gamelin E. Boisdron-Celle M, et al. Among authors: gamelin e. Semin Oncol. 2017 Apr;44(2):161. doi: 10.1053/j.seminoncol.2017.08.002. Epub 2017 Aug 4. Semin Oncol. 2017. PMID: 28923216 No abstract available.
[Oxaliplatin neurotoxicity].
Gamelin L, Boisdron-Celle M, Morel A, Gamelin E. Gamelin L, et al. Among authors: gamelin e. Bull Cancer. 2006 Feb 1;93 Suppl 1:S17-22. Bull Cancer. 2006. PMID: 16491518 Review. French.
[Pharmacokinetic monitoring].
Boisdron-Celle M, Boulanger N, Gamelin E. Boisdron-Celle M, et al. Among authors: gamelin e. Bull Cancer. 2000 Jan;87(1):86-92. Bull Cancer. 2000. PMID: 10673636 Free article. Review. French. No abstract available.
[Pharmacogenetics of anti-cancer drugs].
Gamelin E, Boisdron-Celle M, Morel A, Capitain O. Gamelin E, et al. Ann Pharm Fr. 2007 Nov;65(6):390-401. doi: 10.1016/s0003-4509(07)74198-6. Ann Pharm Fr. 2007. PMID: 18079671 Review. French.
[Pharmacokinetic properties of platinium derivatives].
Boisdron-Celle M, Lebouil A, Allain P, Gamelin E. Boisdron-Celle M, et al. Among authors: gamelin e. Bull Cancer. 2001 Aug;88 Spec No:S14-9. Bull Cancer. 2001. PMID: 11567909 Review. French.
A Phase Ib Open-Label, Multicenter Study of Inhaled DV281, a TLR9 Agonist, in Combination with Nivolumab in Patients with Advanced or Metastatic Non-small Cell Lung Cancer.
Garon EB, Spira AI, Johnson M, Bazhenova L, Leach J, Cummings AL, Candia A, Coffman RL, Janatpour MJ, Janssen R, Gamelin E, Chow LQM. Garon EB, et al. Among authors: gamelin e. Clin Cancer Res. 2021 Aug 15;27(16):4566-4573. doi: 10.1158/1078-0432.CCR-21-0263. Epub 2021 Jun 9. Clin Cancer Res. 2021. PMID: 34108179 Clinical Trial.
[Molecular pharmacogenetics in hospital laboratories in France: current data and future prospects].
Allorge D, Beaune PH, Becquemont L, Bessard G, Bezieau S, Boisdron-Celle M, Boyer JC, Broly F, Dhaneens CM, Fonrose X, Gagnieu MC, Gamelin E, Gozé C, Jacqz-Aigrain E, Loric S, Loriot MA, Marquet P, Morel A, Namour B, Paintaud G, Peoc'h K, Picard N, Watier H, Verstuyft C. Allorge D, et al. Among authors: gamelin e. Ann Pharm Fr. 2007 Nov;65(6):371-81. doi: 10.1016/s0003-4509(07)74196-2. Ann Pharm Fr. 2007. PMID: 18079669 Review. French.
137 results